Evidence map›Paper›PMID 38797526›Full record

ArticleBritish journal of haematology2024

Outcomes of patients with secondary central nervous system lymphoma treated with chimeric antigen receptor T-cell therapy: A CIBMTR analysis.

Narendranath Epperla, Hamza Hashmi, Kwang W Ahn, Mariam Allbee-Johnson, Andy I Chen, Baldeep Wirk, Jennifer A Kanakry, Lazaros Lekakis, Mohamed A Kharfan-Dabaja, Michael Scordo and 7 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Narendranath EpperlaArthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-8216-3457
Hamza HashmiAdult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kwang W AhnDivision of Biostatistics, Medical College of Wisconsin, Institute for Health and Equity, Milwaukee, Wisconsin, USA.
Mariam Allbee-JohnsonCIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Andy I ChenKnight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA.
Baldeep WirkBone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania, USA.
Jennifer A KanakryCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lazaros LekakisDivision of Transplantation and Cellular Therapy, Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics, Miami, Florida, USA.
Mohamed A Kharfan-DabajaDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida, USA.
Michael ScordoAdult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Peter A RiedellDavid and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, Illinois, USA.
Tania JainDivision of Hematological Malignancies and Blood or Marrow Transplantation, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.ORCID https://orcid.org/0000-0001-6854-773X
Mazyar ShadmanFred Hutchinson Cancer Center, University of Washington Medical Center, Seattle, Washington, USA.
Craig SauterDepartment of Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Mehdi HamadaniCIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, Wisconsin, USA.ORCID https://orcid.org/0000-0001-5372-510X
Alex F HerreraDepartment of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA.
Sairah AhmedDepartment of Lymphoma/Myeloma and Stem Cell Transplantation, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID https://orcid.org/0000-0001-7302-8299

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
NIH Hematology Oncology Fellowship ProgramZIEBC010843 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HILL, ELIZABETH · 2009 to 2025
$104.7M
NTP INFORMATION SYSTEMS SUPPORT27305C0011 · NIEHS · Z-TECH CORPORATION · 2007 to 2009
$4.3M
PROVIDE RABBITS, RATS, MICE, HAMSTERS, GERBILS, GUINEA PIGS27307C0011 · NIEHS · PI BOLEN, WAYNE · 2007 to 2007
$500k
Gateway for Cancer ResearchHRSA HHS 75R60222C00011Medical College of WisconsinNational Heart, Lung and Blood InstituteNational Institute of Allergy and Infectious DiseasesNCI NIH HHS P30 CA008748NCI NIH HHS U24 CA076518NCI NIH HHS U24CA076518NIEHS NIH HHS 27305C0011NIEHS NIH HHS 27307C0011NIEHS NIH HHS 27398C0011NMDPOffice of Naval Research N00014-23-1-2057Office of Naval Research N00014-24-1-2507Pediatric Transplantation and Cellular Therapy Consortium
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38797526
PMCPMC11499028

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.